Additional information
Bob Rieder has extensive experience in venture capital and operational management. He is currently President & CEO of Cardiome Pharma Corp. Before joining Cardiome, he was Vice-President at MDS Ventures Pacific Inc., an affiliate of MDS Capital Corp.
Rights and permissions
About this article
Cite this article
Rieder, B. Investing in Biotechnology. Pharmaceutical Innovation 11, 44–45 (2002). https://doi.org/10.1007/BF03265439
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03265439